Stay updated on Daratumumab Therapy in Myeloma with Kidney Failure Clinical Trial
Sign up to get notified when there's something new on the Daratumumab Therapy in Myeloma with Kidney Failure Clinical Trial page.

Latest updates to the Daratumumab Therapy in Myeloma with Kidney Failure Clinical Trial page
- Check5 days agoChange DetectedThe revision history now shows a new version label, updating from v3.6.2 to v3.6.3, indicating an additional revision entry in the page history.SummaryDifference0.1%

- Check12 days agoChange DetectedThe Record History page updated the revision from v3.6.0 to v3.6.2, signaling a newer version of the page history. This reflects an update to the page's metadata rather than substantive changes to study data.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check27 days agoChange DetectedRecruitment status was updated to No longer looking for participants, with the record returned on 2026-06-11 and a pending Quality Control review. The history also adds Outcome Measures sections and updates the revision version to v3.6.0, replacing v3.5.5.SummaryDifference1%

- Check34 days agoChange DetectedA new revision entry (v3.5.5) was added to the study history, becoming the latest version, while the previous revision (v3.5.4) was removed from the current history listing.SummaryDifference0.1%

- Check48 days agoChange DetectedNo text changes (additions or deletions) are present in the provided data.SummaryDifference0.1%

- Check55 days agoChange DetectedRevision v3.5.4 was added to the record history and Revision v3.5.3 was removed, updating the study's version history.SummaryDifference0.2%

Stay in the know with updates to Daratumumab Therapy in Myeloma with Kidney Failure Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Daratumumab Therapy in Myeloma with Kidney Failure Clinical Trial page.